-+ 0.00%
-+ 0.00%
-+ 0.00%

TRAVERE THERAPEUTICS, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $78 FROM $55

Reuters·08/05/2026 03:16:12

Please log in to view news